Literature DB >> 19422782

Avian influenza A(H5N1)--current situation.

A Melidou1.   

Abstract

The A(H5N1) influenza virus has re-emerged in 2003 in Asia, Africa, the Pacific Region as well as Europe and since then has become endemic in some countries. The virus is usually highly pathogenic and is associated with high morbidity and overall mortality rates that reach 61%.

Entities:  

Mesh:

Year:  2009        PMID: 19422782     DOI: 10.2807/ese.14.18.19199-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  5 in total

1.  In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity.

Authors:  Li-Mei Chen; Ola Blixt; James Stevens; Aleksandr S Lipatov; Charles T Davis; Brian E Collins; Nancy J Cox; James C Paulson; Ruben O Donis
Journal:  Virology       Date:  2011-11-05       Impact factor: 3.616

2.  Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.

Authors:  Shailbala Singh; Haroldo Toro; De-Chu Tang; Worthie E Briles; Linda M Yates; Renee T Kopulos; Ellen W Collisson
Journal:  Virology       Date:  2010-06-16       Impact factor: 3.616

3.  The neuropsychiatric aspects of influenza/swine flu: A selective review.

Authors:  Narayana Manjunatha; Suresh Bada Math; Girish Baburao Kulkarni; Santosh Kumar Chaturvedi
Journal:  Ind Psychiatry J       Date:  2011-07

Review 4.  Human H7N9 avian influenza virus infection: a review and pandemic risk assessment.

Authors:  Kang Yiu Lai; George Wing Yiu Ng; Kit Fai Wong; Ivan Fan Ngai Hung; Jeffrey Kam Fai Hong; Fanny Fan Cheng; John Kwok Cheung Chan
Journal:  Emerg Microbes Infect       Date:  2013-08-07       Impact factor: 7.163

5.  Paediatric virology as a candidate of paediatric subspecialisation: An interview with Assistant Professor of Molecular Microbiology-Virology Angeliki Melidou.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2018-07-31       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.